Hostname: page-component-84b7d79bbc-x5cpj Total loading time: 0 Render date: 2024-07-31T03:46:36.589Z Has data issue: false hasContentIssue false
  • English
  • Français

Do we need a more individualised approach to the management of comorbid depression and diabetes?

Part of: BJPsych Advances Cochrane Corner and Round the Corner Collection

Published online by Cambridge University Press:  30 July 2024

Surina Moodley Open the ORCID record for Surina Moodley [Opens in a new window]  and
Panagiotis Pavlou
Surina Moodley*
Affiliation:
Foundation doctor currently working within the Oxford Health NHS Foundation Trust, Oxford, UK. She wishes to pursue training in internal medicine and has an interest in exploring how chronic medical conditions affect mental health.
Panagiotis Pavlou
Affiliation:
Specialty registrar in endocrinology and diabetes currently working in Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK. His main interests lie in the prevention and treatment of complications of diabetes through the recognition of the crucial role of diabetes psychology in the management of the illness and its effect on long-term outcomes.
*
Correspondence Surina Moodley. Email: Surina.Moodley@ouh.nhs.uk
Get access Rights & Permissions [Opens in a new window]

Summary

Diabetes and depression have a bidirectional relationship, but some antidepressants (such as the tricyclics) may have detrimental effects in diabetes that are exacerbated by behavioural changes associated with depression. This month's Cochrane Review evaluated the efficacy of psychological and pharmacological treatments of comorbid depression in diabetes and found that such interventions have a moderate and clinically significant effect on depression outcomes in people with diabetes. However, conclusions were limited by significant heterogeneity within examined populations and interventions, and significant risk of bias within trials. This commentary critically appraises the review and aims to contextualise its findings.

Keywords

Depressive disordersrandomised controlled trialantidepressantsexperimental designstatistical methodology
Type
Round the corner
Information
BJPsych Advances , First View , pp. 1 - 4
Check for updates
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

†

Commentary on… Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression (Cochrane Corner). See this issue.

References

Alruwaili, NS, Al-Kuraishy, HM, Al-Gareeb, AI, et al (2023) Antidepressants and type 2 diabetes: highways to knowns and unknowns. Diabetology & Metabolic Syndrome, 15(1): 179.CrossRefGoogle Scholar
American Diabetes Association (2013) Diagnosis and classification of diabetes Mellitus. Diabetes Care, 37(suppl 1): s81–90.Google Scholar
Baumeister, H, Hutter, N, Bengel, J (2012) Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database of Systematic Reviews, 12: CD008381.Google ScholarPubMed
Gülseren, L, Gülseren, S, Hekimsoy, Z, et al (2005) Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients. Archives of Medical Research, 36: 159–65.CrossRefGoogle ScholarPubMed
Khazaie, H, Rahimi, M, Tatari, F, et al (2011) Treatment of depression in type 2 diabetes with fluoxetine or citalopram? Neurosciences, 16: 41–5.Google ScholarPubMed
Komorousova, J, Beran, J, Rusavy, Z, et al (2010) Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1. Neuroendocrinology Letters, 31: 801–6.Google ScholarPubMed
Krause, M, de Vito, G (2023) Type 1 and type 2 diabetes mellitus: commonalities, differences and the importance of exercise and nutrition. Nutrients, 15(19): 4279.CrossRefGoogle ScholarPubMed
Li, S, Li, M, Song, S (2003) The effect of psychological intervention in treating diabetic patients with negative emotion. Shandong Archives of Psychiatry, 16: 147–8.Google Scholar
Lu, X, Lu, B, Gu, X (2005) Cognitive therapy in combination with electromyographic feedback in treatment of diabetes patients with depression after cerebral infarction. Chinese Journal of Clinical Psychology, 13: 215–6.Google Scholar
Misra, S (2012) Randomized double blind placebo control studies, the 'gold standard' in intervention based studies. Indian Journal of Sexually Transmitted Diseases and AIDS, 33: 131–4.CrossRefGoogle ScholarPubMed
Moulton, CD, Pickup, JC, Ismail, K (2015) The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes & Endocrinology, 3: 461–71.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence (2009) Depression in Adults with a Chronic Physical Health Problem: Recognition and Management (Clinical Guideline CG91). NICE.Google Scholar
National Institute for Health and Care Excellence (2022) Depression. NICE (bnf.nice.org.uk/treatment-summaries/depression/?ref=switch).Google Scholar
Office for National Statistics (2022) Cost of Living and Depression in Adults, Great Britain: 29 September to 23 October 2022. ONS (www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/mentalhealth/articles/costoflivinganddepressioninadultsgreatbritain/29septemberto23october2022).Google Scholar
Paile-Hyvärinen, M, Wahlbeck, K, Eriksson, JG (2003) Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Family Practice, 4: 7.CrossRefGoogle ScholarPubMed
Peinemann, F, Tushabe, DA, Kleijnen, J (2013) Using multiple types of studies in systematic reviews of health care interventions – a systematic review. PLoS One, 8(12): e85035.CrossRefGoogle ScholarPubMed
Petersmann, A, Müller-Wieland, D, Müller, UA, et al (2019) Definition, classification and diagnosis of diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes, 127(suppl 1): S1–7.Google ScholarPubMed
Qu, W, Meng, P (2005) Relationship between blood glucose levels in patients with type 2 diabetes mellitus, depression and anxiety and the anti-depression/anxiety intervention. Chinese Journal of Clinical Rehabilitation, 9: 213–5.Google Scholar
Simson, U, Simson, U, Nawarotzky, U, et al (2007) Effektivitäteiner psychotherapeutischen Intervention im Konsiliardienstauf die depressive Symptomatik bei Patienten mit diabetische Fußsyndrom [Effectiveness of a psychotherapeutic intervention in the consultation service on the depressive symptoms of patients with diabetic foot syndrome]. Verhaltenstherapie, 17(suppl 1): 15–6.Google Scholar
Tamez-Pérez, HE (2015) Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World Journal of Diabetes, 6(8): 1073.CrossRefGoogle ScholarPubMed
van der Feltz-Cornelis, C, Allen, SF, Holt, RIG, et al (2020) Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: systematic review and meta-analysis. Brain and Behavior, 11(2): e01981.CrossRefGoogle ScholarPubMed
Warrington, TP, Michael Bostwick, J (2006) Psychiatric adverse effects of corticosteroids. Mayo Clinic Proceedings, 81: 1361–7.CrossRefGoogle ScholarPubMed
Xue, H (2004) Paroxetine for depression in diabetes: a randomized controlled trial. Zhongguo-Xinli-Weisheng-Zazhi She, 18: 735–7.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.